Age-related femoral bone loss in men: Evidence for hyperparathyroidism and insulin-like growth factor-1 deficiency

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 12, 2004, Pages 1285-1289

  Blain, Hubert ^a   Vuillemin, Anne ^b   Blain, Arielle ^a   Guillemin, Francis ^b   De Talance, Nicole ^c   Doucet, Brigitte ^d   Jeandel, Claude ^a,e  

^a CHU   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CHU NANCY BRABOIS   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e Serv de Medecine Interne Geriatrie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PARATHYROID HORMONE; PRASTERONE SULFATE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGE; AGED; AGING; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BONE DEFECT; BONE DENSITY; BONE REMODELING; BONE TURNOVER; FEMUR NECK; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; HYPERPARATHYROIDISM; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 13444270316     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.12.1285     Document Type: Article

References (41)

1. Ray NF, Chan CK, Thamer M, Melton LJ III. Medical expenditures for the treatment of osteoporosis fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1995;12:24-33.
2. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low bone density in older U.S. Results from NHAES III. J Bone Miner Res. 1997;12:1761-1768.
3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture: an observational study. Lancet. 1999;353:878-882.
4. Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon M, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res. 1998;13:1915-1923.
5. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol. 1995;42:141-146.
6. Edelstein SL, Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol. 1993;138:160-169.
7. Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab. 1999;84:3626-3635.
8. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG. Bone mineral density in femoral neck is positively correlated with circulating insulin-like growth factor (IGF)-I and IGF-binding proteinn (IGFBP)-3 in Swedish men. Calcif Tissue Int. 2002;70:22-29.
9. Sato M, Takeda N, Sarui H, et al. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab. 2001;86: 5273-5276.
10. Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol. 2000;53:561-568.
11. Dagogo-Jack S, Franklin SC, Vijayan A, Liu J, Askari H, Miller SB. Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency. Int J Obes Relat Metab Disord. 1998;22:1110-1115.
12. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987;64:51-58.
13. Kawane T, Horiuchi N. Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH-related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells. Endocrinology. 1999;140:871-879.
14. Barrett-Connor E, Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bemardo Study. J Bone Miner Res. 1998;13:1343-1349.
15. Fatayerji D, Mawer EB, Eastell R. The role of insulin-like growth factor I in age-related changes in calcium homeostasis in men. J Clin Endocrinol Metab. 2000;85:4657-4662.
16. Fatayerji D, Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res. 1999;14:1203-1210.
17. Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res. 2001;16:1642-1650.
18. Clarke BL, Ebeling PR, Jones JD, et al. Changes in quantitative histomorphometry in aging healthy men. J Clin Endocrinol Metab. 1996;81:2264-2270.
19. Orwoll ES, Meier DE. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab. 1986;63:1262-1269.
20. O'Connor KG, Tobin JD, Harman SM, et al. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol Med Sci. 1998;53A:M176-M182.
21. Orwoll ES, Bevan L, Phipps KR. Determinants of bone mineral density in older men. Osteoporos Int. 2000;11:815-821.
22. Taaffe DR, Cauley JA, Danielson M, et al. Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the health, aging and body composition study. J Bone Miner Res. 2001;16:1343-1352.
23. Martinez Diaz-Guerra G, Hawkins F, Rapado A, Ruiz Diaz MA, Diaz-Curiel M. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight. Osteoporos Int. 2001;12:178-184.
24. Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab. 1984;58:223-230.
25. Agnusdei D, Civitelli R, Camporeale A, et al. Age-related decline of bone mass and intestinal calcium absorption in normal males. Calcif Tissue Int. 1998;63:197-201.
26. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab. 1988;67:644-650.
27. Rasmussen H, Wong M, Bikle D, Goodman D. Hormonal control of renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest. 1972;51:2502-2505.
28. Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman SS. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res. 1998;13:475-482.
29. Nicolas V, Prewett A, Bettica P, et al. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab. 1994;78:1011-1016.
30. Hock J, Centrella M, Canalis E. Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication. Endocrinology. 1988;122:254-260.
31. Kawakami A, Nakashima T, Tsuboi M, et al. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochem Biophys Res Commun. 1998;247:46-51.
32. Livshits G, Yakovenko C, Kobyliansky E. Quantitative genetic analysis of circulating levels of biochemical markers of bone formation. Am J Med Genet. 2000;94:324-331.
33. Whiting SJ, Boyle JL, Thompson A, Mirwald RL, Faulkner RA. Dietary protein, phosphorus and potassium are beneficial to bone mineral density in adult men consuming adequate dietary calcium. J Am Coll Nutr. 2002;21:402-409.
34. Kenny AM, Prestwood KM, Marcello KM, Raisz LG. Determinants of bone density in healthy older men with low testosterone levels. J Gerontol Med Sci. 2000;55A:M492-M497.
35. Izumotani K, Hagiwara S, Izumotani T, Miki T, Morii H, Nishizawa Y. Risk factors for osteoporosis in men. J Bone Miner Metab. 2003;21: 86-90.
36. Van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab. 2000;85:3276-3282.
37. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int. 1995;56:104-108.
38. Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3009-3010.
39. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab. 1990;71:1468-1473.
40. Schurch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128:801-809.
41. Ahmad AM, Thomas J, Clewes A, et al. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. Clin Endocrinol Metab. 2003;88:2860-2868.